This year’s conference was fantastic and productive for our company on numerous levels. First of all, our new Backlit Trade Show Booth attracted strong, consistent traffic from interested prospects, partners, and collaborators. Our cool TRANBERG Laser Demo was also a hit showing off our precisely controlled Focal Laser Ablation technology.
Throughout the conference, numerous urologists and potential business partners from the US and EU showed strong interest in our TRANBERG Thermal Therapy system and its minimally invasive approach to treating prostate tissue. We’re currently following up with everyone. Stay tuned for more exciting outcomes!
On behalf of the CLS AUA23 team, thank you to everyone for stopping by. It was my pleasure to meet many of you. I look forward to hopefully hearing from you again in the future should our clinical or business interests align. Best of luck in 2023!
Michael Magnani, President CLS Americas
The CLS team at the AUA2023. Right to Left: Lotta Nilsson,VP Marketing, CLS AB; Rick Wilderotter, Director, Business Development, CLS America’s Inc.; Michael Magnani, President, CLS America’s Inc., and Amani Abou-Zamzam MBA, Urology Strategy Consultant. Joel Hix, Director, Clinical Operations, CLS America’s Inc. (not pictured).
CLS also hosted a private KOL dinner reception where Dr. Fernando Bianco was able to share some early results from our first office-based focal laser ablation cases in America. The first twenty patients have been safely treated and follow up is now ongoing.
Read more about the study here.
Want to learn more about our 510(k) cleared TRANBERG™ products and latest news?
Fill out the form below and we´ll contact you.
Our latest news are displayed below (links to CLS America webpage).
Learn about our progress within the Mobile Service Provider Model enabling more clinics to treat prostate cancer patients.
Listen to a podcast episode with Michael Magnani, President of CLS Americas and Dr Garrett D. Pohlman, urologist at Kearney and the host of the Prostate Health Podcast. They had an engaging discussion around the key features and benefits of using the TRANBERG system for the treatment of low to intermediate localized prostate cancer.
We are happy to introduce Joel Hix, Director of Clinical Operations at CLS Americas. Joel has over 15 years of senior management experience in operations, sales, marketing, and service with leading medical device manufacturers including Boston Scientific and Healthtronics.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region